Literature DB >> 20337891

The del/del genotype of the nuclear factor-kappaB -94ATTG polymorphism and its relation to aggressive periodontitis.

S Schulz1, L Hierse, W Altermann, J Klapproth, U Zimmermann, Y Reichert, C Gläser, A Kluttig, J M Stein, H-G Schaller, S Reichert.   

Abstract

BACKGROUND AND
OBJECTIVE: Periodontitis is influenced by specific host-dependent immune responses. Periodontopathogens induce innate immune responses, amongst others, via toll-like receptor 2 (TLR2), resulting in activation of the nuclear transcription factor nuclear factor-kappaB (NF-kappaB). The aim of this case-control study was to evaluate links between genetic variants of these genes and chronic/aggressive periodontitis in a multivariate model.
MATERIAL AND METHODS: A total of 141 patients with periodontitis (63 with chronic periodontitis and 78 with aggressive periodontitis) and 81 controls without periodontitis were included in the study. Polymorphisms in TLR2 (Arg677Trp, Arg753Gln) and in NF-kappaB (-94ins/delATTG) were determined by restriction fragment length polymorphism and fragment length analyses, respectively. Subgingival bacterial colonization was evaluated using a PCR/DNA probe test (micro-Ident).
RESULTS: Although there was no association of the TLR2 polymorphism Arg753Gln with periodontitis, heterozygous carriers (Arg/Gln) were at a higher risk for colonization with bacteria of the 'red complex' (corrected p-value = 0.042). The del/del genotype of the NF-kappaB polymorphism was associated with aggressive periodontitis considering age, gender, smoking and approximal plaque index as potential confounders (odds ratio = 2.81, p = 0.035, 95% confidence interval: 1.08-7.33). del/del carriers had a higher risk for subgingival colonization with Aggregatibacter actinomycetemcomitans (odds ratio = 2.36, p = 0.030, 95% confidence interval: 1.09-5.1; adjusted for age, gender, smoking and pocket depth(bacteria)).
CONCLUSIONS: The del/del genotype of NF-kappaB was shown to be associated with the occurrence of aggressive periodontitis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20337891     DOI: 10.1111/j.1600-0765.2009.01251.x

Source DB:  PubMed          Journal:  J Periodontal Res        ISSN: 0022-3484            Impact factor:   4.419


  6 in total

1.  Toll-like receptor (TLR) and matrix metalloproteinase (MMP) polymorphisms and periodontitis susceptibility: a meta-analysis.

Authors:  Gwan Gyu Song; Jae-Hoon Kim; Young Ho Lee
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

2.  Glioma Association and Balancing Selection of ZFPM2.

Authors:  Shui-Ying Tsang; Lingling Mei; Weiqing Wan; Jun Li; Yi Li; Cunyou Zhao; Xiaofan Ding; Frank W Pun; Xiaoxia Hu; Jianmin Wang; Junyi Zhang; Rongcheng Luo; Siu-Tim Cheung; Gilberto K K Leung; Wai-Sang Poon; Ho-Keung Ng; Liwei Zhang; Hong Xue
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

3.  Identification of haplotype tag single nucleotide polymorphisms within the nuclear factor-κB family genes and their clinical relevance in patients with major trauma.

Authors:  Wei Pan; An Qiang Zhang; Wei Gu; Jun Wei Gao; Ding Yuan Du; Lian Yang Zhang; Ling Zeng; Juan Du; Hai Yan Wang; Jian Xin Jiang
Journal:  Crit Care       Date:  2015-03-20       Impact factor: 9.097

Review 4.  Periodontal Infectogenomics.

Authors:  Gurjeet Kaur; Vishakha Grover; Nandini Bhaskar; Rose Kanwaljeet Kaur; Ashish Jain
Journal:  Inflamm Regen       Date:  2018-05-07

Review 5.  Association of TLR-2 Gene Polymorphisms with the Risk of Periodontitis: A Meta-Analysis.

Authors:  Chao Shan; Abasijiang Aisaiti; Zhong Peng Wu; Ting Ting Wang; Jin Zhao
Journal:  Dis Markers       Date:  2020-08-06       Impact factor: 3.434

6.  Polymorphism of CD14 Gene Is Associated with Adverse Outcome among Patients Suffering from Cardiovascular Disease.

Authors:  Susanne Schulz; Martin Zielske; Sascha Schneider; Britt Hofmann; Hans-Günter Schaller; Axel Schlitt; Stefan Reichert
Journal:  Mediators Inflamm       Date:  2021-07-08       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.